Clinical trial Recruiting at 1 site Interventional Ages 18 to 40 Women only

Comparing Oxytocin and Carbetocin during Cesarean Sections

Official title: Van Yuzuncu Yil University Faculty of Medicine Ethics Committee

Run by Yuzuncu Yil University · NCT06956365 · Data updated 2026-11-12

This study is testing whether oxytocin or carbetocin is better at managing blood flow and reducing blood loss during cesarean sections for women aged 18-40.

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexWomen only
Enrollment80 (estimated)
SponsorYuzuncu Yil University
Academic / other
Locations1 site (Van, Tuşba)
StatusRecruiting
StartedMay 14, 2024
Main results expectedMay 30, 2025
Study endsJuly 30, 2025
Registry record updatedMay 4, 2025
Trial IDNCT06956365 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are pregnant women aged 18-40 years scheduled for elective cesarean sections with an ASA score of I-II.

Probably not a fit

Patients who prefer spinal or epidural anesthesia or those with significant comorbidities such as hypertension or diabetes may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to compare the effects of two uterotonics, oxytocin and carbetocin, on hemodynamic changes during elective cesarean section surgeries. It will involve 80 patients aged 18-40 years, who will be randomly assigned to receive either oxytocin or carbetocin after general anesthesia induction. Hemodynamic parameters and intraoperative blood loss will be meticulously recorded at various intervals during the surgery to assess the efficacy of each drug. The study is designed as a double-blind trial to ensure unbiased results.

Why it matters

Potential benefit: If successful, this study could lead to improved management of intraoperative hemodynamics during cesarean sections, potentially reducing complications.

How similar studies have gone: Previous studies have shown varying results with uterotonics in cesarean sections, making this approach both relevant and necessary for further exploration.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients scheduled for caesarean sections
* Between 18-40 years
* ASA I-II group
* Those who will undergo general anesthesia
* Those between 35-40 weeks of pregnancy
* 1st and 2nd caesarean sections

Exclusion Criteria:

* Those who prefer spinal or epidural anesthesia
* Those who are outside the age range of 18-40
* Those who are ASA III and above
* Those with HT, DM, cardiac and respiratory diseases
* Preeclampsia, eclampsia, HELLP
* Those with a history of drug use that affects the cardiovascular system
* Placenta Previa, Placenta Acreta, Placenta Acreta

Where it's running

  • Van Yuzuncu Yil University
    Van, Tuşba, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.